Colm Keane is a Hematologist-Oncologist based in Woolloongabba, QLD, Australia. He looks after people who are dealing with blood cancers and other serious blood conditions. Appointments are often about getting answers, mapping out a treatment plan, and making sure patients feel supported through each step.
In his work, Colm focuses on lymphomas and related cancers, including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and classical Hodgkin lymphoma. He also treats Hodgkin lymphoma, nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), and primary mediastinal B-cell lymphoma (PMBCL). At times, this care also covers non-Hodgkin lymphoma types, such as small lymphocytic lymphoma (SLL) and T-cell lymphoma. For many people, the first visit is about explaining what the results mean in plain terms, and what options might fit best.
Colm also cares for patients with blood cancers like chronic lymphocytic leukemia (CLL) and chronic B-cell leukemia (CBCL). In some cases, treatment plans may involve monitoring for changes, managing symptoms, or using therapies aimed at controlling the disease. He understands that blood conditions can affect energy levels, immunity, and day-to-day life, so care is not only about scans and blood tests, but also about the practical side of coping.
Along with cancers, he treats related conditions that can be harder to deal with. This can include agranulocytosis, and other problems that may show up with low blood counts. Some patients also come in for help around mediastinal tumours and other issues that need a careful, step-by-step approach.
Colm’s specialist training covers haematology and oncology, so he can connect the dots between blood work, imaging, and treatment decisions. Over time, he helps patients work through complex results and make choices that feel manageable. Where appropriate, treatment may include options linked with clinical research or clinical trials, depending on what fits the patient’s situation. More detailed information about education, publications, and clinical trials can be discussed during appointments.
